Costall B, Naylor R J
Postgraduate Studies in Pharmacology, School of Pharmacy, University of Bradford, West Yorkshire, UK.
Int Clin Psychopharmacol. 1993 Nov;8 Suppl 2:11-8. doi: 10.1097/00004850-199311002-00002.
Dumuis and colleagues (1988) in their investigation of a 5-HT receptor positively linked to adenylate cyclase in the central nervous system, concluded that the receptor was not 5-HT1, 5-HT2 or 5-HT3-like and suggested that it belonged to a new class of 5-HT receptor called 5-HT4. A similar, if not identical receptor was located by Craig and Clark (1990) in the guinea pig ileum and a functional role for the peripheral 5-HT4 receptor has since been established in many species to mediate muscle contraction or relaxation within the gut and positive inotropic effects in the heart. In contrast, a functional role for central 5-HT4 receptors has remained obscure. Using measurements of rodent behaviour in the mouse light and dark test box and rat social interaction, anxiolytic agents such as diazepam and putative anxiolytic agents such as the 5-HT1A and 5-HT3 receptor ligands 8-OH-DPAT and low doses of tropisetron release behaviour suppressed by the aversive situation. 5-Hydroxytryptophan has the opposite effect exacerbating the behavioural response to the aversive situation. But an anxiolytic profile is revealed by co-treatment with ritanserin plus 5-hydroxytryptophan. The drug-induced anxiolytic profiles are inhibited by SDZ205-557 and a high dose of tropisetron. Both compounds are 5-HT3/5-HT4 receptor antagonists yet the selective 5-HT3 receptor antagonist ondansetron fails to inhibit the drug-induced anxiolytic profiles.(ABSTRACT TRUNCATED AT 250 WORDS)
杜米斯及其同事(1988年)在对中枢神经系统中与腺苷酸环化酶呈正相关的5-羟色胺(5-HT)受体进行研究时得出结论,该受体不像5-HT1、5-HT2或5-HT3,他们认为它属于一类名为5-HT4的新型5-HT受体。克雷格和克拉克(1990年)在豚鼠回肠中发现了一种类似(即便不完全相同)的受体,此后已证实外周5-HT4受体在许多物种中具有功能性作用,可介导肠道内的肌肉收缩或舒张以及心脏的正性肌力作用。相比之下,中枢5-HT4受体的功能性作用仍不清楚。通过测量小鼠明暗试验箱中的啮齿动物行为以及大鼠的社交互动,发现地西泮等抗焦虑药以及5-HT1A和5-HT3受体配体8-羟基二苯丙氨酸(8-OH-DPAT)和低剂量托烷司琼等假定抗焦虑药可释放被厌恶情境抑制的行为。5-羟色氨酸具有相反的作用,会加剧对厌恶情境的行为反应。但与利坦色林加5-羟色氨酸联合治疗可显示出抗焦虑特征。药物诱导的抗焦虑特征受到SDZ205-557和高剂量托烷司琼的抑制。这两种化合物都是5-HT3/5-HT4受体拮抗剂,但选择性5-HT3受体拮抗剂昂丹司琼无法抑制药物诱导的抗焦虑特征。(摘要截选至250词)